Genetic disorders and sleepiness

Sleepiness: Causes, Consequences and Treatment

Volumn , Issue , 2011, Pages 335-350

  Nevsimalova, Sona ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84905081455     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511762697.032     Document Type: Chapter

References (54)

1. Dorris L, Scott N, Zuberi S, et al.Sleep problems in children with neurological disorders. Develop Neurorehab, 2008; 11:95–114.
2. Menkes J H, Falk E. Chromosomal anomalies and contiguous-gene syndromes. In: Menkes J H, Sarnat HB, Maria B L, Eds. Child Neurology (7th Ed.), Philadelphia Lippincott Williams and Wilkins, 2006: 227–257.
3. Harvey MT, Kennedy CH. Polysomnographic phenotypes in developmental disabilities. Int J Devl Neuroscience, 2002; 20: 443–448.
4. Rack MJ. Sleep disorders associated with mental retardation. In: Culebras A, Ed. Sleep Disorders and Neurologic Diseases(2nd Ed.). New York, NY: Informa Healthcare, 2007: 27–37.
5. Dominguez-Ortega L, Salin-Pascual R J, Diaz-Gallego E. Narcolepsy-like symptoms in a patient with Down syndrome and without obstructive sleep apnea. Sleep, 2003; 26:285–86.
6. Harvey M T, Kennedy C H. Polysomnographic phenotypes in developmental disabilities. Int J Dev Neurosci, 2002; 20:443–48.
7. Gould E L, Loesch D Z, Martin MJ, et al.Melatonin profiles and sleep characteristics in boys with fragile X syndrome: a preliminary study. Am J Med Genet, 2000; 95:307–15.
8. Hagerman R. Fragile X: treatment of hyperactivity. Pediatrics, 1997; 99:753.
9. Weiskop S, Richdale A, Matthews J. Behavioural treatment to reduce sleep problems in children with autism or fragile X syndrome. Dev Med Child Neurol, 2005; 47:94–104.
10. Pulst SM (Ed). Neurogenetics. New York, NY:Oxford University Press, 2000.
11. Camfferman D, Mc Evoy R D, O’Donoghue F, et al.Prader Willi syndrome and excessive daytime sleepiness. Sleep Med Rev, 2008; 12:65–75.
12. Menendez A A. Abnormal ventilatory responses in patients with Prader–Willi syndrome. Eur J Pediatr, 1999; 158:941–42.
13. Nevsimalova S, Vankova J, Stepanova I, et al.Hypocretin deficiency in Prader–Willi syndrome. Eur J Neurol, 2005; 12:70–72.
14. Fronczek R, Lammers G J, Balesar R, et al.The number of hypothalamic hypocretin (orexin) neurons is not affected in Prader–Willi syndrome. J Clin Endocrinol Metab, 2005; 90:5466–70.
15. Zhdanova I V, Wurtman R J, Wagstaff J. Effect of a low dose of melatonin on sleep in children with Angelman syndrome. J Pediatr Endocrinol Metab, 1999; 12:57–67.
16. Arens R, Wright B, Elliot J, et al.Periodic limb movement in sleep in children with Williams syndrome. J Pediatr, 1998; 133:670–74.
17. Goldman S E, Malow B A, Newman K D, et al.Sleep patterns and daytime sleepiness in adolescents and young adults with Williams syndrome. J Intel Dis Res, 2009; 53:182–88.
18. De Leersnyder H. Inverted rhythm of melatonin secretion in Smith–Magenis syndrome: from symptoms to treatment. Trends Endocrin Metab, 2006; 17:291–98.
19. Shelley B P, Robertson MM. The neuropsychiatry and multisystem features of the Smith–Magenis syndrome. a review. J Neuropsychiatry Clin Neurosci, 2005; 17:91–97.
20. Trivier E, De Cesare D, Jacquot S, et al.Mutation in the kinase Rsk-2 associated with Coffin–Lowry syndrome. Nature, 1996; 384:567–70.
21. Nelson G B, Hahn J S. Stimulus-induced drop episodes in Coffin–Lowry syndrome. Pediatrics, 2003; 111:e197–202.
22. Caraballo R, Tesi Rocha A, Medina C, et al.Drop episodes in Coffin–Lowry syndrome: an unusual type of startle response. Epileptic Disord, 2000; 2: 173–76.
23. Vossler D G, Wyler A R, Wilkus R J, et al.Cataplexy and monoamine oxidase deficiency in Norrie disease. Neurology, 1996; 46:1258–61.
24. Menkes J H, Wilcox WR. Inherited metabolic diseases of the nervous system. In: Menkes J H, Sarnat HB, Maria B L, Eds. Child Neurology(7th Ed.). Philadelphia, PA: Lippincott Williams and Wilkins, 2006: 29–141.
25. Philippe A, Deron J, Genevieve, D, et al.Neurodevelopmental pattern of succinic semialdehyde dehydrogenase deficiency (gamma-hydroxybutyric aciduria). Develop Med Child Neurol, 2004; 46: 564–68.
26. Mellies U, Stehling F, Dohna-Schwake C, et al.Respiratory failure in Pompe disease: treatment with noninvasive ventilation. Neurology, 2005; 64:1465–67.
27. Leighton S E J, Papsin B, Vellodi A, et al.Disordered breathing during sleep in patients with mucopolysaccharidoses. Int J Pediatr Otorhinolaryngol, 2001; 58:127–38.
28. Santamaria F, Andreucci MV, Parenti G, et al.Upper airway obstructive disease in mucopolysaccharidoses: polysomnography, computed tomography and nasal endoscopy findings. J Inherit Metab Dis, 2007; 30:743–49.
29. Fraser J, Wraith J E, Delatycki MB. Sleep disturbance in mucopolysaccharidoses type III (Sanfilippo syndrome): a survey of managing clinicians. Clin Genet, 2002; 62:418–21.
30. Guerrero JM, Pozo D, Diaz-Rodrigues J L, et al.Impairment of the melatonin rhythm in children with Sanfilippo syndrome. J Pineal Res, 2006; 40:192–93.
31. Vankova J, Stepanova I, Jech R, et al.Sleep disturbances and hypocretin deficiency in Niemann–Pick disease type C. Sleep, 2003; 26:427–30.
32. Kanbayashi T, Abe M, Fujimoto S, et al.Hypocretin deficiency in Niemann–Pick type C with cataplexy. Neuropediatrics, 2003; 34:52–53.
33. Nishino S, Kanbayashi T. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Sleep, 2005; 9:269–310.
34. Oyama K, Takahashi T, Shoji Y, et al.Niemann–Pick disease type C: cataplexy and hypocretin in cerebrospinal fluid. Tokohu J Exp Med, 2006; 209:263–67.
35. Vanier MT. Biochemical studies in Niemann–Pick disease. I. Major sphingolipids of liver and spleen. Biochim Biophys Acta, 1983; 750:178–84.
36. Challamel MJ, Mazzola ME, Nevsimalova S, et al.Narcolepsy in children. Sleep, 1994; 17:17–20.
37. Kirveskari E, Partinen M, Santavuori P. Sleep and its disturbance in a variant form of late infantile neuronal ceroid lipofuscinosis (CLN5). J Child Neurol, 2001; 16:707–13.
38. Kirveskari E, Partinen M, Salmi T, et al.Sleep alteration in juvenile neuronal ceroid-lipofuscinosis. Pediatr Neurol, 2000; 22:347–54.
39. Portala K, Westermark K, Ekselius L, et al.Sleep in patients with treated Wilson’s disease. A questionnaire study. Nord J Psychiatry, 2002; 56:291–97.
40. Nevsimalova S, Buskova J, Skibova J, et al.Sleep disorders in Wilson disease – a questionnaire study. The 50th anniversary of paradoxical sleep discovery, Lyon, 7–10 January 2009.
41. Valind S, Nennesmo I, Lundberg P O, et al.Neuroimaging study in autosomal dominant cerebellar ataxias, deafness, and narcolepsy. Neurology, 1999; 53:2190–92.
42. Friedman J H, Fernandez H H, Sudarsky L R. REM behavior disorder and excessive daytime somnolence in Machado–Joseph disease (SCA-3). Mov Disord, 2003; 18:1520–22.
43. Menkes J H. Heredodegenerative diseases. In: Menkes J H, Sarnat H B, Maria B L, Eds. Child Neurology(7th Ed.). Philadelphia, PA: Lippincott Williams and Wilkins, 2006: 163–226.
44. Young D, Nagarajn L, de Klerk N, et al.Sleep problems in Rett syndrome. Brain Dev, 2007; 29:609–16.
45. Nomura Y. Neurophysiology of Rett syndrome. Brain Dev, 2001; 23:S50–57.
46. Kinsbourne M, Wood F B. Disorders of mental development. In: Menkes J H, Sarnat HB, Maria B L, Eds. Child Neurology(7th Ed.). Philadelphia, PA: Lippincott Williams and Wilkins, 2006: 1097–156.
47. Liu X, Hubbard J A, Fabes R A, et al.Sleep disturbances and correlates of children with autism spectrum disorders. Child Psychiatry Hum Dev, 2006; 37:179–91.
48. Mann S C, Campbell E C, Caroff S N, et al.Psychiatric aspects of movement disorders in sleep. In: Chokroverty S, Hening WA, Walkers A S, Eds. Sleep and Movement Disorders. Philadelphia, PA: Butterwoth Heinemann, 2003: 511–26.
49. Owens J A. The ADHD and sleep conundrum: a review. J Dev Behav Ped, 2005; 26:312–22.
50. Rodnitzky R L. Sleep in Parkinson’s disease. In: Culebras A, Ed. Sleep Disorders and Neurologic Diseases(2nd Ed.). New York, NY: Informa Healthcare, 2007: 205–28.
51. Alves R S C, Resende MB D, Skomro R, et al.Sleep and neuromuscular disorders in children. Sleep Med Rev, 2009; 13:133–48.
52. Culebras A. Sleep disorders and neuromuscular disorders. In: Culebras A, Ed. Sleep Disorders and Neurologic Diseases(2nd Ed.). New York, NY: Informa Healthcare, 2007: 387–403.
53. Sarnat H B, Menkes J H. Diseases of the motor unit. In: Menkes J H, Sarnat HB, Maria B L, Eds. Child Neurology(7th Ed.). Philadelphia, PA: Lippincott Williams and Wilkins, 2006: 969–1024.
54. Aboussouan L S, Lewis R A, Shy ME. Disorders of pulmonary functions, sleep and the upper airway in Charcot–Marie–Tooth disease. Lung, 2007; 185: 1–7.